Vladan Vučinić

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Wolfgang Bethge, Jolanta Dengler, M Bornhäuser et al. · Leukemia · 2012 · 228 citations

Hematological Malignancy, Transplantation, Medicine +9

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Wolfgang Bethge, Peter Martus, Michael Schmitt et al. · Blood · 2022 · 210 citations · Full text

High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis

Daniel Fürst, Carlheinz Müller, Vladan Vučinić et al. · Blood · 2013 · 204 citations

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Peter Borchmann, Justin Ferdinandus, Gundolf Schneider et al. · The Lancet · 2024 · 87 citations · Full text

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study

Wolfgang Bethge, Thoralf Lange, Christoph Meisner et al. · Blood · 2010 · 76 citations · Full text